US Initial Jobless Claims (Oct/24) 194.0K vs. Exp. 199K (Prev. 195.0K)
Newsquawk Staff ·
US Initial Jobless Claims (Oct/24) 194.0K vs. Exp. 199K (Prev. 195.0K)
What it means
A weekly claims print of this size, a modest beat against consensus with the prior unrevised in substance, sits in the range that has historically moved the front end only marginally; the series carries weight when it signals a trend break rather than when it confirms one. In past cycles the market's read on claims has hinged on whether the level is drifting off its floor, since sustained upticks have tended to precede deterioration in the payrolls survey with a lag, while low and stable prints have reinforced the soft-landing framing embedded in front-end pricing. The distinctions that matter are the four-week average versus the single week, and continuing claims versus initial filings, the former pair smoothing noise from holiday timing and weather, the latter separating hiring hesitation from layoff activity. Seasonal adjustment around holiday-heavy stretches has repeatedly produced prints that were revised or reversed in subsequent weeks, which is why single-week beats of this magnitude rarely reprice the policy path on their own. The follow-ons are the next claims print for confirmation, the continuing claims trajectory, and how this feeds into the prevailing narrative ahead of the next payrolls report, which remains the release that actually moves the curve.
- Mastercard Incorporated (MA) Q3 2026 (USD): Adj. EPS 5.31 (exp. 5.17), Revenue 9.8bln (exp. 9.66bln)
- Merck & Co. Inc. (MRK) Q3 (USD) Adj. EPS 2.49 (exp. 2.09), Revenue 18.1bln (exp. 17.34bln), Current FY Adj EPS 2.77 (exp. 2.64), Current FY Rev. 66.8-67.3bln (exp. 67.05bln)
- [MARKET ANALYSIS] DXY off best levels but with an upward bias ahead of US GDP and PCE, EUR awaits ECB, and AUD lags
- US President Trump is reportedly seriously considering resuming military strikes against Iran shortly after the US midterms if diplomacy fails, while the US remains engaged in negotiations over a temporary peace deal, Semafor reports
- EUROPEAN OPEN: Some of BP/ LN board favour breakup; DTE GY delays TMUS merger bid; STM profits up, sales outlook beats; VOW3 GY operating loss; ADS GY raises profit view; ABI BB Q3 volumes rise; GLE FP Q2 net income beats; AIR FP profit beat, sales miss
Related headlines
- US GDP Sales Adv (Q3 QQ) 1.7% (Prev. 2.8%)20 min ago
- US PCE Price Index (Sep MM) 0.5% vs. Exp. 0.5% (Prev. 0.3%)20 min ago
- US Personal Spending (Sep MM) 0.5% vs. Exp. 0.6% (Prev. 0.9%)20 min ago
- US Core PCE Index (Sep YY) 3.1% vs. Exp. 3.1% (Prev. 3.0%)20 min ago
- US PCE Price Index (Sep YY) 3.6% vs. Exp. 3.6% (Prev. 3.4%)20 min ago
- US Core PCE Index (Sep MM) 0.3% vs. Exp. 0.3% (Prev. 0.3%)20 min ago
- US Personal Income (Sep MM) 0.2% vs. Exp. 0.3% (Prev. 0.3%)20 min ago
- US Jobless Claims 4-week Average (Oct/24) 196.75K (Prev. 198.0K)20 min ago
- US Continuing Jobless Claims (Oct/17) 1701.0K vs. Exp. 1720K (Prev. 1722.0K)20 min ago
- US GDP Growth Rate Adv (Q3 QQ) 3.4% vs. Exp. 3.2% (Prev. 2.2%)20 min ago
- Bristol-Myers Squibb Company (BMY) Q3 2026 (USD): Adj. EPS 1.35 (exp. 1.10), Revenue 13.07bln (exp. 12.72bln)1 hour ago
- Irish GDP Growth Rate Prel (Q3 QQ) 5.5% (Prev. 10.2%)1 hour ago
- Italian Business Confidence (Oct) 91.9 vs. Exp. 92 (Prev. 91.9)1 hour ago
- Quanta Services Inc. (PWR) Q3 2026 (USD) Adj. EPS 6.06 (exp. 5.02), Revenue 12bln (exp. 11.03bln), says the long-term outlook for Quanta's business is positive1 hour ago
- Eli Lilly and Company (LLY) Q3 2026 (USD): adj. EPS 7.48 (exp. 5.68), Revenue 24.4bln (exp. 22.58bln); Mounjaro 10.7bln, Zepbound 5.3bln. Current FY Rev. 91-92bln (exp. 88.82bln)2 hours ago